RegentAtlantic Capital’s VYNE Therapeutics VYNE Stock Holding History

RegentAtlantic Capital’s Portfolio VYNE Stock Details VYNE Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell
2022 Q2	$10K	Buy
2021 Q1	–	Sell
2020 Q4	$24K	Hold
2020 Q3	$25K	Hold
2020 Q2	$26K	Buy